Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

CA125 expression in epithelioid sarcoma.

Hiroshi Kato¹, Masahito Hatori, Shoichi Kokubun

¹Department of Orthopedic Surgery, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan.

Japanese Journal of Clinical Oncology

|April 14, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

BCOR-CCNB3 fusion-positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up.

Frontiers in oncology·2026

Same author

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity.

Frontiers in oncology·2026

Same author

NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept study.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Disappearance of histone H3F3A mutation in metastatic giant cell tumor of bone during long term follow up.

Discover oncology·2026

Same author

Nationwide epidemiologic study of osteochondroma in Japan: Analysis of 4843 cases from the bone and soft tissue tumor registry.

Journal of bone oncology·2026

Same author

A case report of autogenous bone grafting using fibula regenerated from beta-tricalcium phosphate for a bone tumor: application of the in vivo bioreactor principle.

BMC musculoskeletal disorders·2026

Same journal

Characterization of distant metastases in salivary gland cancer patients undergoing upfront surgery followed by postoperative radiation therapy: a multicenter analysis.

Japanese journal of clinical oncology·2026

Same journal

A Lynch syndrome patient with multiple cancers who was found to have a novel pathogenic variant generating aberrant splicing of MLH1.

Japanese journal of clinical oncology·2026

Same journal

Age-standardized mortality-to-incidence ratio for lymphoma in the world.

Japanese journal of clinical oncology·2026

Same journal

Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.

Japanese journal of clinical oncology·2026

Same journal

Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment.

Japanese journal of clinical oncology·2026

Same journal

Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer.

Japanese journal of clinical oncology·2026

See all related articles

This study identifies CA125 as a highly positive and specific immunohistological marker for epithelioid sarcoma (ES). CA125 shows promise as a valuable tool for accurately diagnosing epithelioid sarcoma.

Area of Science:

Oncology
Pathology
Immunohistochemistry

Background:

Epithelioid sarcoma (ES) diagnosis lacks established immunohistological markers.
Accurate diagnostic tools are crucial for effective ES treatment and management.

Purpose of the Study:

To investigate the diagnostic utility of CA125 as an immunohistological marker for epithelioid sarcoma.
To determine the positivity and specificity of CA125 in ES compared to other soft tissue tumors and granulomas.

Main Methods:

Immunohistochemical analysis of CA125 was performed on 11 ES cases, 78 other soft tissue tumors, and 9 granulomas.
Additional markers including EMA, cytokeratin, CEA, vimentin, and CD34 were analyzed in ES patients.

Main Results:

Related Experiment Videos

CA125 was strongly expressed in 10 out of 11 epithelioid sarcoma cases.
None of the other soft tissue tumors or granulomas expressed CA125, demonstrating high specificity.
EMA, cytokeratin, and vimentin were also positive in all ES cases.

Conclusions:

CA125 demonstrates significant positivity and specificity for epithelioid sarcoma.
CA125 is proposed as a potentially useful tumor marker for the diagnosis of ES.